Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study

  1. Bhoo-Pathy, Nirmala
  2. Peeters, Petra HM
  3. Uiterwaal, Cuno SPM
  4. Bueno-de-Mesquita, H Bas
  5. Bulgiba, Awang M
  6. Bech, Bodil Hammer
  7. Overvad, Kim
  8. Tjønneland, Anne
  9. Olsen, Anja
  10. Clavel-Chapelon, Françoise
  11. Fagherazzi, Guy
  12. Perquier, Florence
  13. Teucher, Birgit
  14. Kaaks, Rudolf
  15. Schütze, Madlen
  16. Boeing, Heiner ORCID logo
  17. Lagiou, Pagona
  18. Orfanos, Philippos
  19. Trichopoulou, Antonia
  20. Agnoli, Claudia
  21. Mattiello, Amalia
  22. Palli, Domenico
  23. Tumino, Rosario
  24. Sacerdote, Carlotta
  25. van Duijnhoven, Franzel JB
  26. Braaten, Tonje
  27. Lund, Eiliv
  28. Skeie, Guri
  29. Redondo, María-Luisa
  30. Buckland, Genevieve
  31. Pérez, Maria José Sánchez
  32. Chirlaque, Maria-Dolores
  33. Ardanaz, Eva
  34. Amiano, Pilar
  35. Wirfält, Elisabet
  36. Wallström, Peter
  37. Johansson, Ingegerd
  38. Nilsson, Lena Maria
  39. Khaw, Kay-Tee
  40. Wareham, Nick
  41. Allen, Naomi E
  42. Key, Timothy J
  43. Rinaldi, Sabina
  44. Romieu, Isabelle
  45. Gallo, Valentina
  46. Riboli, Elio
  47. van Gils, Carla H

Download
13058_2015_Article_521.pdf 445,51KB
WeightNameValue
1000 Titel
  • Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study
1000 Autor/in
  1. Bhoo-Pathy, Nirmala |
  2. Peeters, Petra HM |
  3. Uiterwaal, Cuno SPM |
  4. Bueno-de-Mesquita, H Bas |
  5. Bulgiba, Awang M |
  6. Bech, Bodil Hammer |
  7. Overvad, Kim |
  8. Tjønneland, Anne |
  9. Olsen, Anja |
  10. Clavel-Chapelon, Françoise |
  11. Fagherazzi, Guy |
  12. Perquier, Florence |
  13. Teucher, Birgit |
  14. Kaaks, Rudolf |
  15. Schütze, Madlen |
  16. Boeing, Heiner |
  17. Lagiou, Pagona |
  18. Orfanos, Philippos |
  19. Trichopoulou, Antonia |
  20. Agnoli, Claudia |
  21. Mattiello, Amalia |
  22. Palli, Domenico |
  23. Tumino, Rosario |
  24. Sacerdote, Carlotta |
  25. van Duijnhoven, Franzel JB |
  26. Braaten, Tonje |
  27. Lund, Eiliv |
  28. Skeie, Guri |
  29. Redondo, María-Luisa |
  30. Buckland, Genevieve |
  31. Pérez, Maria José Sánchez |
  32. Chirlaque, Maria-Dolores |
  33. Ardanaz, Eva |
  34. Amiano, Pilar |
  35. Wirfält, Elisabet |
  36. Wallström, Peter |
  37. Johansson, Ingegerd |
  38. Nilsson, Lena Maria |
  39. Khaw, Kay-Tee |
  40. Wareham, Nick |
  41. Allen, Naomi E |
  42. Key, Timothy J |
  43. Rinaldi, Sabina |
  44. Romieu, Isabelle |
  45. Gallo, Valentina |
  46. Riboli, Elio |
  47. van Gils, Carla H |
1000 Erscheinungsjahr 2015
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2015-01-31
1000 Erschienen in
1000 Quellenangabe
  • 17: 15
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2015
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13058-015-0521-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349221/ |
1000 Ergänzendes Material
  • https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0521-3#Declarations |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCTION: Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. METHODS: A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. RESULTS: During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR = 0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; P trend = 0.029. While there was no significant effect modification by hormone receptor status (P = 0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P = 0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR = 0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose–response relationship (P trend = 0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR = 0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. CONCLUSIONS: Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/Qmhvby1QYXRoeSwgTmlybWFsYQ==|https://frl.publisso.de/adhoc/creator/UGVldGVycywgUGV0cmEgSE0=|https://frl.publisso.de/adhoc/creator/VWl0ZXJ3YWFsLCBDdW5vIFNQTQ==|https://frl.publisso.de/adhoc/creator/QnVlbm8tZGUtTWVzcXVpdGEsIEggQmFz|https://frl.publisso.de/adhoc/creator/QnVsZ2liYSwgQXdhbmcgTQ==|https://frl.publisso.de/adhoc/creator/QmVjaCwgQm9kaWwgSGFtbWVy|https://frl.publisso.de/adhoc/creator/T3ZlcnZhZCwgS2lt|https://frl.publisso.de/adhoc/creator/VGrDuG5uZWxhbmQsIEFubmU=|https://frl.publisso.de/adhoc/creator/T2xzZW4sIEFuamE=|https://frl.publisso.de/adhoc/creator/Q2xhdmVsLUNoYXBlbG9uLCBGcmFuw6dvaXNl|https://frl.publisso.de/adhoc/creator/RmFnaGVyYXp6aSwgR3V5|https://frl.publisso.de/adhoc/creator/UGVycXVpZXIsIEZsb3JlbmNl|https://frl.publisso.de/adhoc/creator/VGV1Y2hlciwgQmlyZ2l0|https://frl.publisso.de/adhoc/creator/S2Fha3MsIFJ1ZG9sZg==|https://frl.publisso.de/adhoc/creator/U2Now7x0emUsIE1hZGxlbg==|http://orcid.org/0000-0002-3358-1775|https://frl.publisso.de/adhoc/creator/TGFnaW91LCBQYWdvbmE=|https://frl.publisso.de/adhoc/creator/T3JmYW5vcywgUGhpbGlwcG9z|https://frl.publisso.de/adhoc/creator/VHJpY2hvcG91bG91LCBBbnRvbmlh|https://frl.publisso.de/adhoc/creator/QWdub2xpLCBDbGF1ZGlh|https://frl.publisso.de/adhoc/creator/TWF0dGllbGxvLCBBbWFsaWE=|https://frl.publisso.de/adhoc/creator/UGFsbGksIERvbWVuaWNv|https://frl.publisso.de/adhoc/creator/VHVtaW5vLCBSb3Nhcmlv|https://frl.publisso.de/adhoc/creator/U2FjZXJkb3RlLCBDYXJsb3R0YQ==|https://frl.publisso.de/adhoc/creator/dmFuIER1aWpuaG92ZW4sIEZyYW56ZWwgSkI=|https://frl.publisso.de/adhoc/creator/QnJhYXRlbiwgVG9uamU=|https://frl.publisso.de/adhoc/creator/THVuZCwgRWlsaXY=|https://frl.publisso.de/adhoc/creator/U2tlaWUsIEd1cmk=|https://frl.publisso.de/adhoc/creator/UmVkb25kbywgTWFyw61hLUx1aXNh|https://frl.publisso.de/adhoc/creator/QnVja2xhbmQsIEdlbmV2aWV2ZQ==|https://frl.publisso.de/adhoc/creator/UMOpcmV6LCBNYXJpYSBKb3PDqSBTw6FuY2hleg==|https://frl.publisso.de/adhoc/creator/Q2hpcmxhcXVlLCBNYXJpYS1Eb2xvcmVz|https://frl.publisso.de/adhoc/creator/QXJkYW5heiwgRXZh|https://frl.publisso.de/adhoc/creator/QW1pYW5vLCBQaWxhcg==|https://frl.publisso.de/adhoc/creator/V2lyZsOkbHQsIEVsaXNhYmV0|https://frl.publisso.de/adhoc/creator/V2FsbHN0csO2bSwgUGV0ZXI=|https://frl.publisso.de/adhoc/creator/Sm9oYW5zc29uLCBJbmdlZ2VyZA==|https://frl.publisso.de/adhoc/creator/Tmlsc3NvbiwgTGVuYSBNYXJpYQ==|https://frl.publisso.de/adhoc/creator/S2hhdywgS2F5LVRlZQ==|https://frl.publisso.de/adhoc/creator/V2FyZWhhbSwgTmljaw==|https://frl.publisso.de/adhoc/creator/QWxsZW4sIE5hb21pIEU=|https://frl.publisso.de/adhoc/creator/S2V5LCBUaW1vdGh5IEo=|https://frl.publisso.de/adhoc/creator/UmluYWxkaSwgU2FiaW5h|https://frl.publisso.de/adhoc/creator/Um9taWV1LCBJc2FiZWxsZQ==|https://frl.publisso.de/adhoc/creator/R2FsbG8sIFZhbGVudGluYQ==|https://frl.publisso.de/adhoc/creator/Umlib2xpLCBFbGlv|https://frl.publisso.de/adhoc/creator/dmFuIEdpbHMsIENhcmxhIEg=
1000 Label
1000 Förderer
  1. European Commission |
  2. International Agency for Research on Cancer |
  3. Danish Cancer Society |
  4. Ligue contre le Cancer, France |
  5. Mutuelle Générale de l’Education Nationale, France |
  6. Institut National de la Santé et de la Recherche Medicale, France |
  7. Deutsche Krebshilfe |
  8. Deutsches Krebsforschungszentrum |
  9. Federal Ministry of Education and Research, Germany |
  10. Hellenic Health Foundation, Greece |
  11. Italian Association for Research on Cancer (AIRC) |
  12. National Research Council, Italy |
  13. Dutch Ministry of Public Health, Welfare and Sports (VWS) |
  14. Netherlands Cancer Registry (NKR) |
  15. LK Research Funds, Netherlands |
  16. Dutch Prevention Funds, Netherlands |
  17. Dutch ZON (Zorg Onderzoek Nederland) |
  18. World Cancer Research Fund (WCRF), Netherlands |
  19. Statistics Netherlands |
  20. NordForsk, Norway |
  21. Health Research Fund (FIS), Spain |
  22. Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, Spain |
  23. ISCIII RETIC, Spain |
  24. Swedish Cancer Society |
  25. Swedish Scientific Council |
  26. Regional Government of Skåne and Västerbotten, Sweden |
  27. Cancer Research UK |
  28. Medical Research Council, UK |
  29. European Union |
  30. Ministry of Higher Education, Malaysia |
1000 Fördernummer
  1. -
  2. -
  3. -
  4. -
  5. -
  6. -
  7. -
  8. -
  9. -
  10. -
  11. -
  12. -
  13. -
  14. -
  15. -
  16. -
  17. -
  18. -
  19. -
  20. 070015
  21. -
  22. -
  23. RD06/0020
  24. -
  25. -
  26. -
  27. -
  28. -
  29. MY/AsiaLink/044 (128–713)
  30. UM.C/HIR/MOHE/06
1000 Förderprogramm
  1. DG-SANCO
  2. -
  3. -
  4. -
  5. -
  6. -
  7. -
  8. -
  9. -
  10. -
  11. -
  12. -
  13. -
  14. -
  15. -
  16. -
  17. -
  18. -
  19. -
  20. Centre of Excellence programme HELGA
  21. -
  22. -
  23. -
  24. -
  25. -
  26. -
  27. -
  28. -
  29. AsiaLink program
  30. High Impact Research Grant
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer European Commission |
    1000 Förderprogramm DG-SANCO
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer International Agency for Research on Cancer |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Danish Cancer Society |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer Ligue contre le Cancer, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  5. 1000 joinedFunding-child
    1000 Förderer Mutuelle Générale de l’Education Nationale, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  6. 1000 joinedFunding-child
    1000 Förderer Institut National de la Santé et de la Recherche Medicale, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  7. 1000 joinedFunding-child
    1000 Förderer Deutsche Krebshilfe |
    1000 Förderprogramm -
    1000 Fördernummer -
  8. 1000 joinedFunding-child
    1000 Förderer Deutsches Krebsforschungszentrum |
    1000 Förderprogramm -
    1000 Fördernummer -
  9. 1000 joinedFunding-child
    1000 Förderer Federal Ministry of Education and Research, Germany |
    1000 Förderprogramm -
    1000 Fördernummer -
  10. 1000 joinedFunding-child
    1000 Förderer Hellenic Health Foundation, Greece |
    1000 Förderprogramm -
    1000 Fördernummer -
  11. 1000 joinedFunding-child
    1000 Förderer Italian Association for Research on Cancer (AIRC) |
    1000 Förderprogramm -
    1000 Fördernummer -
  12. 1000 joinedFunding-child
    1000 Förderer National Research Council, Italy |
    1000 Förderprogramm -
    1000 Fördernummer -
  13. 1000 joinedFunding-child
    1000 Förderer Dutch Ministry of Public Health, Welfare and Sports (VWS) |
    1000 Förderprogramm -
    1000 Fördernummer -
  14. 1000 joinedFunding-child
    1000 Förderer Netherlands Cancer Registry (NKR) |
    1000 Förderprogramm -
    1000 Fördernummer -
  15. 1000 joinedFunding-child
    1000 Förderer LK Research Funds, Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  16. 1000 joinedFunding-child
    1000 Förderer Dutch Prevention Funds, Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  17. 1000 joinedFunding-child
    1000 Förderer Dutch ZON (Zorg Onderzoek Nederland) |
    1000 Förderprogramm -
    1000 Fördernummer -
  18. 1000 joinedFunding-child
    1000 Förderer World Cancer Research Fund (WCRF), Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  19. 1000 joinedFunding-child
    1000 Förderer Statistics Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  20. 1000 joinedFunding-child
    1000 Förderer NordForsk, Norway |
    1000 Förderprogramm Centre of Excellence programme HELGA
    1000 Fördernummer 070015
  21. 1000 joinedFunding-child
    1000 Förderer Health Research Fund (FIS), Spain |
    1000 Förderprogramm -
    1000 Fördernummer -
  22. 1000 joinedFunding-child
    1000 Förderer Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, Spain |
    1000 Förderprogramm -
    1000 Fördernummer -
  23. 1000 joinedFunding-child
    1000 Förderer ISCIII RETIC, Spain |
    1000 Förderprogramm -
    1000 Fördernummer RD06/0020
  24. 1000 joinedFunding-child
    1000 Förderer Swedish Cancer Society |
    1000 Förderprogramm -
    1000 Fördernummer -
  25. 1000 joinedFunding-child
    1000 Förderer Swedish Scientific Council |
    1000 Förderprogramm -
    1000 Fördernummer -
  26. 1000 joinedFunding-child
    1000 Förderer Regional Government of Skåne and Västerbotten, Sweden |
    1000 Förderprogramm -
    1000 Fördernummer -
  27. 1000 joinedFunding-child
    1000 Förderer Cancer Research UK |
    1000 Förderprogramm -
    1000 Fördernummer -
  28. 1000 joinedFunding-child
    1000 Förderer Medical Research Council, UK |
    1000 Förderprogramm -
    1000 Fördernummer -
  29. 1000 joinedFunding-child
    1000 Förderer European Union |
    1000 Förderprogramm AsiaLink program
    1000 Fördernummer MY/AsiaLink/044 (128–713)
  30. 1000 joinedFunding-child
    1000 Förderer Ministry of Higher Education, Malaysia |
    1000 Förderprogramm High Impact Research Grant
    1000 Fördernummer UM.C/HIR/MOHE/06
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6405729.rdf
1000 Erstellt am 2017-12-07T15:49:32.287+0100
1000 Erstellt von 218
1000 beschreibt frl:6405729
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet Thu Mar 04 08:27:23 CET 2021
1000 Objekt bearb. Thu Mar 04 08:27:22 CET 2021
1000 Vgl. frl:6405729
1000 Oai Id
  1. oai:frl.publisso.de:frl:6405729 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source